Intravenous Anesthetics for the Treatment of Chronic Pain and Psychiatric or Substance Use Disorders
Customize your policy alerts
Sign up for Premera Bluecross Policy 5.01.586 alerts
Get alerted when Policy 5.01.586 changes without checking for updates manually.
Monitor payer policy activity
Defines coverage position for intravenous infusion of anesthetics (e.g., ketamine, lidocaine) when used to treat chronic pain syndromes (including neuropathic pain, chronic daily headache, fibromyalgia) and psychiatric disorders (including depression, anxiety, OCD, PTSD, and substance use disorders). Also lists applicable CPT/HCPCS codes and summarizes evidence and guidance.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.